Treat-to-target strategies are conditionally recommended for patients with active PsA, although alternative strategies may be considered in response to concerns about:
a. adverse events
d. a and b only
e. all of the above
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.